Bernard Escudier Selected Research

Bernard Escudier Research Topics

Disease

230	Renal Cell Carcinoma (Grawitz Tumor) 05/2022 - 07/2003
106	Neoplasms (Cancer) 02/2022 - 03/2002
35	Kidney Neoplasms (Kidney Cancer) 01/2021 - 04/2002
21	Fatigue 01/2020 - 01/2007
15	Disease Progression 01/2021 - 01/2007
15	Neoplasm Metastasis (Metastasis) 10/2018 - 01/2006
13	Hypertension (High Blood Pressure) 01/2022 - 01/2007
11	Melanoma (Melanoma, Malignant) 01/2020 - 03/2002
8	Hypoxia (Hypoxemia) 10/2016 - 01/2007
7	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 03/2003
7	Diarrhea 10/2018 - 01/2007
6	Exanthema (Rash) 10/2016 - 01/2007
6	Carcinoma (Carcinomatosis) 11/2015 - 05/2007
4	Stomatitis 01/2020 - 08/2008
4	Pain (Aches) 11/2018 - 03/2002
4	Nausea 10/2018 - 03/2007
4	Proteinuria 12/2015 - 01/2011
3	Dyspnea (Shortness of Breath) 10/2018 - 06/2007
3	Hyperglycemia 10/2016 - 03/2014
3	Pneumonia (Pneumonitis) 03/2014 - 08/2008
3	Clear-cell metastatic renal cell carcinoma 03/2014 - 12/2012
3	Asthenia 03/2013 - 12/2007
3	Alopecia (Baldness) 12/2011 - 03/2007
2	Pruritus (Itching) 01/2020 - 02/2009
2	Brain Neoplasms (Brain Tumor) 10/2019 - 02/2014
2	Body Weight (Weight, Body) 04/2018 - 11/2015
2	Stomach Neoplasms (Stomach Cancer) 10/2017 - 10/2014
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2017 - 03/2011
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2017 - 10/2010
2	Anemia 12/2016 - 11/2015
2	Posterior Leukoencephalopathy Syndrome 10/2016 - 02/2014
2	Hypercholesterolemia 10/2016 - 03/2014
2	Edema (Dropsy) 12/2015 - 04/2012
2	Renal Insufficiency (Renal Failure) 09/2013 - 05/2007
2	Hand-Foot Syndrome 05/2013 - 07/2008
2	Cough 04/2012 - 06/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2012 - 08/2009
2	Keratoacanthoma 01/2012 - 08/2009

Drug/Important Bio-Agent (IBA)

63	Sunitinib (Sutent)FDA Link 02/2022 - 01/2008
44	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022 - 06/2004
37	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 05/2006
34	Everolimus FDA Link 01/2022 - 08/2008
30	Bevacizumab (Avastin)FDA Link 02/2022 - 12/2007
27	NivolumabIBA 01/2022 - 11/2015
24	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2006
21	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2020 - 08/2005
18	Biomarkers (Surrogate Marker)IBA 09/2021 - 06/2004
17	Immune Checkpoint InhibitorsIBA 05/2022 - 11/2015
17	cabozantinibIBA 01/2022 - 11/2015
15	Axitinib (AG 013736)IBA 06/2020 - 01/2011
13	CytokinesIBA 03/2020 - 03/2002
12	IpilimumabIBA 01/2022 - 04/2018
12	Interleukin-2 (IL2)IBA 12/2017 - 03/2002
10	TOR Serine-Threonine KinasesIBA 01/2019 - 08/2008
9	Pharmaceutical PreparationsIBA 01/2021 - 03/2002
9	Biological ProductsIBA 11/2018 - 08/2003
8	atezolizumabIBA 02/2022 - 01/2018
8	Peptides (Polypeptides)IBA 01/2020 - 02/2004
8	Interferon-alpha (Interferon Alfa)IBA 03/2017 - 01/2006
8	InterferonsIBA 08/2016 - 04/2002
8	temsirolimus FDA Link 10/2015 - 09/2008
7	pazopanib FDA Link 12/2021 - 01/2011
7	Proteins (Proteins, Gene)FDA Link 10/2016 - 10/2002
5	LigandsIBA 02/2022 - 02/2005
5	B7-H1 AntigenIBA 01/2022 - 10/2016
5	Phosphotransferases (Kinase)IBA 01/2022 - 07/2005
5	Angiogenesis InhibitorsIBA 12/2021 - 12/2005
5	AntigensIBA 01/2020 - 03/2002
5	Monoclonal AntibodiesIBA 08/2017 - 06/2014
4	MTOR InhibitorsIBA 10/2015 - 08/2010
4	Interferon alpha-2 (Roferon-A)FDA Link 05/2010 - 12/2007
3	Messenger RNA (mRNA)IBA 06/2020 - 03/2002
3	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 06/2014 - 03/2013
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2008 - 10/2002
3	HLA-A2 Antigen (HLA A2 Antigen)IBA 03/2005 - 02/2004
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2022 - 12/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2018
2	Amylases FDA Link 10/2019 - 12/2015
2	CrizotinibIBA 11/2018 - 12/2017
2	tivozanibIBA 11/2018 - 08/2014
2	Tyrosine (L-Tyrosine)FDA Link 10/2018 - 10/2002
2	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 10/2010
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 05/2007
2	InterleukinsIBA 08/2016 - 06/2007
2	AndrogensIBA 01/2016 - 09/2015
2	Interleukin-6 (Interleukin 6)IBA 11/2015 - 06/2004
2	Epidermal Growth Factor (EGF)IBA 07/2014 - 12/2012
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 06/2014 - 03/2013
2	Carbonic Anhydrase IXIBA 12/2012 - 10/2010
2	Gemcitabine FDA Link 05/2012 - 05/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2012 - 11/2009
2	PlatinumIBA 05/2012 - 05/2007

Therapy/Procedure

120	Therapeutics 12/2021 - 03/2002
26	Nephrectomy 01/2022 - 12/2005
11	Immunotherapy 03/2020 - 03/2002
11	Drug Therapy (Chemotherapy) 01/2017 - 07/2003
5	Radiotherapy 11/2018 - 04/2014
5	Castration 01/2016 - 05/2009
3	Injections 10/2009 - 03/2002
2	Molecular Targeted Therapy 06/2016 - 02/2014